Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Real-world experience and outcomes of decitabine/cedazuridine or azacitidine for the treatment of myelodysplastic syndrome/chronic myelomonocytic leukemia.
Journal: Leukemia & lymphoma
Published: November 06, 2025
Real-world experience with CPX-351 for secondary acute myeloid leukaemia: Comparison with FLAG-IDA in a propensity score matching analysis.
Journal: British journal of haematology
Published: August 28, 2025
Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma.
Journal: Current oncology (Toronto, Ont.)
Published: January 16, 2025
Early Cardiovascular Events in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: JACC. Advances
Published: December 23, 2024
Improvement in quality of life in MDS patients who become transfusion independent after treatment.
Journal: Leukemia & lymphoma
Published: November 09, 2024
Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS.
Journal: Transplantation and cellular therapy
Published: July 18, 2024
Concurrent BCR-ABL1 and core binding factor beta rearrangement in de novo acute myeloid leukemia: A case report and review of literature.
Journal: EJHaem
Published: January 14, 2024
Healthcare provider's perceptions of bleeding in patients with acute leukaemia undergoing induction chemotherapy: A qualitative study.
Journal: Transfusion medicine (Oxford, England)
Published: January 09, 2024
Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes.
Journal: JCO oncology practice
Published: February 10, 2023
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry.
Journal: Leukemia & lymphoma
Published: January 06, 2023
Last Updated: 09/26/2026